Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2025, Vol. 21 ›› Issue (02): 211 -218. doi: 10.3877/cma.j.issn.1673-5250.2025.02.013

Original Article

Neurofibromatosis type 1 complicated with nephrotic syndrome:a case report and literature review

Xiaohui Li1, Donglei Liu1, Ronghao Zheng1, Songbai Zhu1, Xiaolin Wu1,()   

  1. 1. Department of Pediatric Nephropathy,Rheumatology and Immunology,Hubei Maternal and Child Health Hospital,Wuhan 430070,Hubei Proviuce,China
  • Received:2024-09-18 Revised:2025-02-08 Published:2025-04-01
  • Corresponding author: Xiaolin Wu

Objective

To explore the clinical characteristics and diagnosis of children with neurofibromatosis type 1(NF1)complicated with nephrotic syndrome(NS),and to investigate the potential association mechanism between NF1 and NS through a literature review.

Methods

A 12-year-old male child with NF1 complicated with NS (Child 1)who was admitted to the Hubei Maternal and Child Health Hospital affiliated to Huazhong University of Science and Technology in February 2021 was selected as the research subject.A retrospective analysis was conducted to collect the clinical data,whole-exome sequencing(WES)results,and Sanger sequencing validation results of child 1.The pathogenicity of the detected variants was analyzed according to the guidelines established by the American College of Medical Genetics and Genomics (ACMG).Keywords such as"neurofibromatosis type 1""nephrotic syndrome""nephritis"and their English equivalents were used to search relevant literature in databases such as Wanfang Data Service Platform,China National Knowledge Infrastructure (CNKI),and Pub Med.The search period was set from January 1,2001,to December 30,2024.This study adhered to the requirements of the revised 2013 DeclarationofHelsinkiofthe WorldMedicalAssociation.Informed consent was obtained from the guardians of the child.

Results

①Child 1,a boy,was admitted to the pediatric nephrology and rheumatology immunology department of Hubei Maternal and Child Health Hospital on January 14,2021,due to"generalized edema for 2 days".Physical examination upon admission revealed café-au-lait spots over the entire body,multiple small freckles in both axillae,and two tumors approximately 0.5 cm in size in the right renal area.Laboratory tests showed massive proteinuria,hypoalbuminemia,and hyperlipidemia,leading to a diagnosis of NF1 complicated with NS.After admission,the child was treated with adequate glucocorticoids to induce remission,and proteinuria turned negative before discharge.Seven days after discharge,the child again presented with proteinuria without any identifiable cause.Renal biopsy histopathological examination suggested podocyte lesions.Whole-exome sequencing(WES)revealed a deletion mutation (6361-6362del TC)in exon 42 of the NF1 gene on chromosome 17(NM_001042492),causing a frameshift variant,which met the ACMG pathogenicity criteria.Treatment with methylprednisolone tablets combined with tacrolimus was administered,and proteinuria turned negative again before discharge.②Literature review:A total of 17 patients were included,aged 3 to 70 years,with childhood-onset in 5 cases (29.4%).Ten cases (58.8%)were confirmed to have NF1 through genetic testing.The types of renal injury associated with NF1 included membranous nephropathy,focal segmental glomerulosclerosis (FSGS),and Ig A nephropathy.

Conclusions

NF1 complicated with NS is clinically rare,and genetic testing is crucial for a definitive diagnosis.Abnormalities in the m TOR signaling pathway may mediate podocyte damage,leading to proteinuria.Combined treatment with glucocorticoids and immunosuppressants may be an effective therapeutic approach.

图1 患儿1(男性,12岁)皮肤照片图(图1A:躯干皮肤可见牛奶咖啡斑;图1B:右肾区可见2处直径约为0.5 cm 瘤体,红色箭头所示) 注:患儿1为1型神经纤维瘤病合并肾病综合征
图2 患儿1(男性,12岁)肾穿刺活检病理学切片电镜图[图2A:肾小球毛细血管襻足突弥漫融合(红色箭头所示),系膜区可见高密度电子致密物沉积,绿色箭头所示(电镜,×6 000);图2B:肾小球轻微病变(HE染色,高倍);图2C:肾小球系膜细胞和基质轻度增生(PAS染色,高倍);图2D:肾小球基底膜无明显增厚(PASM 染色,高倍)] 注:患儿1为1型神经纤维瘤病合并肾病综合征,HE染色为苏木素-伊红染色,PAS染色为过碘酸-雪夫染色,PASM 染色为六铵银染色
图3 患儿1(男性,12 岁龄)及其家系成员NF1 基因Sanger测序图 注:患儿1为1型神经纤维瘤病合并肾病综合征
表1 纳入文献复习的17例NF1合并NS/肾炎患者临床资料比较
患儿编号 文献(第1作者,发表年) 性别/年龄(岁) NF1家族史 NF1诊断结果 合并肾病/肾炎类型 肾穿刺 治疗方案/疗效
1 本研究 男/12 NF1 基因移码变异位点为c.6361_c.6362delTC,p.Ser2121Hisfs*7(NM_001042492),皮下神经纤维瘤+咖啡斑 NS足细胞病 激素+他克莫司/CR
2 Lin[7],2017 男/62 NF1 基因杂合移码突变c.1541_1542delAG, p.Gln514fs) THSD7A 相关膜性肾病 ACEI+ 激素+ 环磷酰胺/无缓解
3 Wani[14],2006 女/70 皮下神经纤维瘤+咖啡斑 膜性肾病 —/—
4 Lin[7],2017 男/49 皮下神经纤维瘤+咖啡斑 —/—
5 林芙君[16],2022 男/68 皮下神经纤维瘤+咖啡斑+腋窝雀斑 膜性肾病 —/自发性蛋白尿缓解
6 Varyani[9],2019 男/51 NF1 基因突变a C1q肾病 激素+ 环磷酰胺治疗/—
7 Cheng[5],2024 男/9 NF1 基因第1外显子c.55G>T(p.E19*) NS 激素治疗敏感(首次缓解2周内),后续多次复发后加用他克莫司/—
8 Hyun[11],2015 女/29 皮肤活检b MCD 切除L3~4神经根丛状纤维瘤后6 个月/CR
9 Afshinnia Fd[15],2013 女/42 17号染色体NF1 基因存在突变a FSGS ACEI/PR
10 Gersch[13],2006 男/22 NF1 基因突变a FSGS —/—
11 Tarrass[4],2008 男/58 临床症状诊断b FSGS ACEI/—
12 Chang[12],2015 女/44 临床症状诊断b IgM 肾病 ACEI+激素/CR
13 Van-Gils[10], 2014 男/4 NF1 基因第20外显子c.3443C>A,p.Ala1148Glu NS 激素/PR
14 Orera[8],2019 女/41 临床症状诊断b MCD 激素+环磷酰胺/PR
15 Rhee[6],2021 男/51 NF1 基因突变a IgA肾病Ⅲ级 ACEI/PR
16 刘竹枫[17],2022 男/3 NF1 基因第8外显子c.844C>T NS 激素/CR
17 刘竹枫[17],2022 男/10 NF1 基因第11外显子c.1246C>T MCD 激素+霉酚酸酯/CR
[1]
中华医学会儿科学分会肾脏学组.儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016)[J].中华儿科杂志,2017,55(10):729-734.DOI:10.3760/cma.j.issn.0578-1310.2017.10.003.The Subspecialty Group of Renal Diseases,the Society of Pediatrics,Chinese Medical Association.Evidence-based guideline on diagnosis and treatment of steroid-sensitive,relapsing/steroid-dependent nephrotic syndrome in children(2016) [J].Chin J Pediatr,2017,55(10):729-734.DOI:10.3760/cma.j.issn.0578-1310.2017.10.003.
[2]
郭艺桢,袁芳,陈育才.1型神经纤维瘤病发病机制的研究进展[J].国际儿科学杂志,2024,51(1):23-28.DOI:10.3760/cma.j.issn.1673-4408.2024.01.005.Guo YZ,Yuan F,Chen YC.Progress on the pathogenesis of neurofibromatosis type 1[J].Int J Pediatr,2024,51(1):23-28.DOI:10.3760/cma.j.issn.1673-4408.2024.01.005.
[3]
智元昭,曹璐,窦文杰,等.利妥昔单抗治疗儿童非复杂性激素依赖型肾病综合征疗效分析[J/OL].中华妇幼临床医学杂志(电子版),2023,19(1):54-60.DOI:10.3877/cma.j.issn.1673-5250.2023.01.008.Zhi YZ,Cao L,Dou WJ,et al.Efficacy of rituximab in the treatment of uncomplicated steriod-dependent nephrotic syndrome in children [J/OL].Chin J Obstet Gynecol Pediatr(Electron Ed),2023,19(1):54-60.DOI:10.3877/cma.j.issn.1673-5250.2023.01.008.
[4]
Tarrass F.Focal and segmental glomerulosclerosis and von Recklinghausen's neurofibromatosis:coincidental or associated?[J].Saudi J Kidney Dis Transpl,2008,19(3):453-454.
[5]
Cheng B,Yang H,Huang L,et al.Nephrotic syndrome in a child with neurofibromatosis type 1:a case report and literature review[J].Nephrology (Carlton),2024,29(12):973-976.DOI:10.1111/nep.14393.
[6]
Rhee H,Kim S,Lee W,et al.Immunoglobulin A nephropathy in a patient with neurofibromatosis type 1:a case report and literature review[J].Medicine (Baltimore),2021,100(42):e27572.DOI:10.1097/MD.0000000 000027572.
[7]
Lin F,Zhang D,Chang J,et al.THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1[J].Eur J Med Genet,2018,61(2):84-88.DOI:10.1016/j.ejmg.2017.10.014.
[8]
Orera A,Lacarra S,Fernández L,et al.Secondary glomerulonephritis in neurofibromatosis type 1.Two case reports[J].An Sist Sanit Navar,2019,42(3):345-349.Spanish.DOI:10.23938/ASSN.0720.
[9]
Varyani UT,Shah NM,Shah PR,et al.C1q nephropathy in a patient of neurofibromatosis type 1:a rare case report[J].Indian J Nephrol,2019,29(2):125-127.DOI:10.4103/ijn.IJN_353_17.
[10]
Van-Gils J,Harambat J,Jubert C,et al.Atypical hematologic and renal manifestations in neurofibromatosis typeⅠ:coincidence or pathophysiological link? [J].Eur J Med Genet,2014,57(11-12):639-642.DOI:10.1016/j.ejmg.2014.09.001.
[11]
Hyun JI,Min JW,Lee HM,et al.Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a typeⅠneurofibromatosis patient[J].Korean J Intern Med,2017,32(1):186-189.DOI:10.3904/kjim.2015.016.
[12]
Chang KY,Kim HW,Kim YS.Case of immunoglobulin M nephropathy in a patient with neurofibromatosis type 1[J].Nephrology (Carlton),2015,20(9):666-667.DOI:10.1111/nep.12487.
[13]
Gersch MS,Talor Z.Focal segmental glomerular sclerosis in a patient with neurofibromatosis typeⅠ[J].Am J Kidney Dis,2006,47(1):e17-e19.DOI:10.1053/j.ajkd.2005.09.017.
[14]
Wani MM,Reshi AR,Banday KA,et al.von Recklinghausen's neurofibromatosis associated with membranous glomerulonephritis[J].Saudi Med J,2006,27(4):534-535.
[15]
Afshinnia F,Vega-Warner V,Killen P.Focal segmental glomerulosclerosis in association with neurofibromatosis type 1:a case report and proposed molecular pathways[J].Clin Kidney J,2013,6(2):208-210.DOI:10.1093/ckj/sft010.
[16]
林芙君,张丹,常娟,等.1型神经纤维瘤病患者的THSD7A相关膜性肾病1例 [J].中国临床案例成果数据库,2022,4(1):E06390-E06390.DOI:10.3760/cma.j.cmcr.2022.e06390.Lin FJ,Zhang D,Chang J,et al.A case of membranous nephropathy associated with THSD7A in a patient with neurofibromatosis type 1[J].Chin J Clin Case Res Database,2022,4(1):E06390-E06390.DOI:10.3760/cma.j.cmcr.2022.e06390.
[17]
刘竹枫,王文红,郭珍,等.两例散发1型神经纤维瘤病合并肾病综合征患儿的遗传学分析[J].中华医学遗传学杂志,2022,39(12):1349-1353.DOI:10.3760/cma.j.cn511374-20210916-00755.Liu ZF,Wang WH,Guo Z,et al.Genetic analysis of two sporadic cases of neurofibromatosis type 1 in children with nephrotic syndrome[J].Chin J Med Genet,2022,39(12):1349-1353.DOI:10.3760/cma.j.cn511374-20210916-00755.
[18]
张超,滕利.神经纤维瘤病的相关因素与治疗进展[J].中国美容医学杂志,2010,19(1):133-136.DOI:10.3969/j.issn.1008-6455.2010.01.062.Zhang C,Teng L.Research progress on related factors and treatment of neurofibromatosis[J].Chin J Beaut Med,2010,19(1):133-136.DOI:10.3969/j.issn.1008-6455.2010.01.062.
[19]
Srinivasan A,Krishnamurthy G,Fontalvo-Herazo L,et al.Spectrum of renal findings in pediatric fibromuscular dysplasia and neurofibromatosis type 1[J].Pediatr Radiol,2011,41(3):308-316.DOI:10.1007/s00247-010-1854-9.
[20]
Kokubo T,Hiki Y,Horii A,et al.Recklinghausen's neurofibromatosis associated with membranous nephropathy[J].Nephron,1993,65(3):486.DOI:10.1159/000 187543.
[21]
Bollag G,McCormick F.Ras regulation.NF is enough of GAP[J].Nature,1992,356(6371):663-664.DOI:10.1038/356663a0.
[22]
Shaw RJ,Cantley LC.Ras,PI(3)K and m TOR signalling controls tumour cell growth[J].Nature,2006,441(7092):424-430.DOI:10.1038/nature04869.
[23]
Fehrenbacher N,Bar-Sagi D,Philips M.Ras/MAPK signaling from endomembranes[J].Mol Oncol,2009,3(4):297-307.DOI:10.1016/j.molonc.2009.06.004.
[24]
Huynh C,Ryu J,Lee J,et al.Nutrient-sensing m TORC1 and AMPK pathways in chronic kidney diseases[J].Nat Rev Nephrol,2023,19(2):102-122.DOI:10.1038/s41581-022-00648-y.
[25]
Adella A,de Baaij J.m TOR signaling in renal ion transport[J].Acta Physiol( Oxf),2023,238(1):e13960.DOI:10.1111/apha.13960.
[26]
Ito N,Nishibori Y,Ito Y,et al.m TORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome[J].Lab Invest,2011,91(11):1584-1595.DOI:10.1038/labinvest.2011.135.
[27]
Gödel M,Hartleben B,Herbach N,et al.Role of m TOR in podocyte function and diabetic nephropathy in humans and mice[J].J Clin Invest,2011,121(6):2197-2209.DOI:10.1172/JCI44774.
[28]
Koshikawa M,Mukoyama M,Mori K,et al.Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome[J].J Am Soc Nephrol,2005,16(9):2690-2701.DOI:10.1681/ASN.2004121084.
[29]
Sakai N,Wada T,Furuichi K,et al.p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis[J].Nephrol Dial Transplant,2002,17(6):998-1004.DOI:10.1093/ndt/17.6.998.
[30]
Whaley-Connell A,Habibi J,Panfili Z,et al.AngiotensinⅡactivation of m TOR results in tubulointerstitial fibrosis through loss of N-cadherin[J].Am J Nephrol,2011,34(2):115-125.DOI:10.1159/000329327.
[1] Xiuzhen Yang, Li Li, Zheming Xu, Jingjing Wang, Jingjing Ye. Contrast-enhanced voiding urosonography-based assessment of intrarenal reflux: spatial correlation of intrarenal reflux with DMSA scintigraphy findings[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(04): 348-353.
[2] Jiaoyan Tan, Li Yuan, Shen Jing, Wudan Guo, Wenjing Wu. Clinical application of two-dimensional shear wave elastography in evaluation of splenomegaly in children[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2025, 22(03): 247-252.
[3] Yongwei Zhang, Yuhua Liu. An exploratory study on using Nomograms to distinguishing Mycoplasma pneumoniae from viral infection in children aged 0 to 12 years old with community-acquired pneumonia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 180-188.
[4] Jing Liu, Yanhua Chai, Yanbo Lai, Liyan Ma. Clinical features and treatment of renal abscess in children[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 189-194.
[5] Wenwen Cai, Xia Guo, Ju Gao, Yiping Zhu, Xiaoqian Lu, Xue Yang, Zhi Wan, Shuwen Sun. Efficacy analysis of CCLG-AML-2015 protocol in the treatment of children with newly diagnosed acute myeloid leukemia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 195-201.
[6] Yinyin Wu, Jihong Tang, Xiao Xiao, Liya Zhang, Jiwen Wang. Clinical characteristics of Mollaret meningitis in children:a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2025, 21(02): 202-210.
[7] Aihong Zhao, Weijuan Tang, Junjian Fu, Xiang Xu. Construction and validation of a line chart prediction model for post infectious bronchiolitis obliterans in children with severe pneumonia[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2025, 19(02): 77-83.
[8] Pei Li, Hailong Zhang, Jiayang Mao, Darong Xu, Jing Zhao. Dynamic changes of heparin binding protein and interleukin-6 levels in children with lobar pneumonia and analysis of their correlation with disease severity[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2025, 19(02): 84-95.
[9] Miao Sun, Shengde Wu. Robot-assisted technology for treating pediatric hydronephrosis:a scope review[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(01): 95-102.
[10] Lijie Fan, Yali Wei. Effect of S(+)-ketamine and sufentanil on intraoperative hemodynamics and postoperative spontaneous recovery in children undergoing laparoscopic high ligation of hernia sac[J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2025, 19(02): 214-218.
[11] Kuilin Lyu, Hong Chen. Analysis of epidemiological and clinical characteristics of 465 pediatric cases of Mycoplasma pneumoniae pneumonia: a single-center retrospective study[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 55-61.
[12] Wenhai Bao, Qin Ruan, Feifei Li. Application value of Th17/Treg immune imbalance in the diagnosis and disease evaluation of children with abdominal Henoch-Schonlein purpura[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(02): 162-167.
[13] Yi Wang. Significance of serum pepsinogen in detection of Helicobacter pylori-associated gastritis in children[J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(02): 140-144.
[14] Yun Wang, Lei Liu, Min Xu, De Huai. Clinical efficacy and safety of dupilumab injection combined with Yupingfeng granules in treatment of moderate to severe atopic dermatitis in children[J]. Chinese Journal of Clinicians(Electronic Edition), 2025, 19(01): 27-32.
[15] Rongchang Wu, Xiaolian Fang, Lei Yang, Chengyue Zhang, Junyang Zhao, Yun Peng, Jia You, Jie Yin. Complications of intra-arterial chemotherapy for retinoblastomas:a single-center study analysis[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2025, 13(01): 49-53.
Viewed
Full text


Abstract